Hadassah

Hadassah Hosts Israel Heart Society Conference Highlighting Israel’s Cardiac Innovations

Tuesday, Apr 30 2013

With Prof. Chaim Lotan, head of Hadassah's Heart Institute and Outgoing President of the Israel Heart Society (IHS) as host along with IHS Secretary-General Dr. Amit Segev, over 1,000 cardiologists from around the world participated in the IHS's international conference in Jerusalem, celebrating its 60th anniversary and spotlighting Israel's major contributions to the treatment of cardiovascular disease.

Commemorating three of these cardiac contributions, Israel's Philatelic Service recently issued three new postage stamps. One features a percutaneous (inserted through the skin) artificial heart valve; another highlights stents (metal mesh cylinders that release medication and hold open damaged or collapsed coronary arteries); and a third contains an illustration of an implanted defibrillator that electrically regulates a heartbeat. The stamps were unveiled at the IHS conference by Philatelic Service Director Yaron Razon.

Among the leading foreign guests at the conference were American College of Cardiology President Prof. John Harold and European Society of Cardiology President Prof. Panos Vardas. In an interview with The Jerusalem Post, Prof. Harold, a cardiologist at Cedar-Sinai Medical Center in California, related that he has trained many Israeli cardiologists and described the growth of cardiac services in Israel as "nothing short of extraordinary." He also commented: "Israeli cardiologists have great bench-to-bedside developments. Israel is one of the safest parts of the world to have a heart attack."

Prof. Lotan told the audience that the mortality rate from cardiovascular disease has dropped in recent decades by half, and that 90 percent of acute cardiovascular events are treated immediately with catheterization. In addition, he noted that in the last four years, about 1,500 artificial heart valves have been implanted via catheter to replace faulty ones in patients for whom open-heart surgery is counterindicated.

Read more in The Jerusalem Post>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More